Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR2 | P21802 | 2/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | CTSA | P10619 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.38 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | PTPRC | P08575 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.37 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.37 |
| ▸ | FEN1 | P39748 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15119769 | 0.91 | ADORA3 (0.43) | FGFR2FGFR1ADORA3PTGS2PTPRC | |
| SCHEMBL17791127 | 0.90 | ALOX5AP (0.40) | FGFR2FGFR1ADORA3CTSAPDE3B | |
| SCHEMBL16771252 | 0.89 | ADORA3 (0.42) | FGFR2FGFR1ADORA3PTGS2PTPRC | |
| SCHEMBL17791125 | 0.89 | PPARD (0.41) | PDE3BPDE3AALOX5APFEN1KDM4E | |
| SCHEMBL21609904 | 0.88 | FGFR2 (0.44) | FGFR2FGFR1ADORA3PTGS2PTPRC | |
| SCHEMBL20010658 | 0.88 | FGFR2 (0.41) | FGFR2FGFR1ADORA3PTGS2PTPRC | |
| SCHEMBL17791128 | 0.88 | PPARD (0.40) | PDE3BPDE3AALOX5APFEN1MAPT | |
| SCHEMBL17791126 | 0.87 | FGFR2 (0.41) | FGFR2FGFR1PTGS2PTPRCNAAA | |
| SCHEMBL17791131 | 0.87 | RARB (0.42) | ALOX5APFEN1MAPTALDH1A1NPSR1 | |
| SCHEMBL16855917 | 0.86 | FGFR2 (0.46) | FGFR2FGFR1PTGS2PTPRCNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230333428-A1 | LIQUID CRYSTAL DISPLAY DEVICE | Sharp Display Technology Corporation (JP) | 2023-10-19 | — | — | US | disclosed |
| WO-2021253624-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT OR LIQUID CRYSTAL DISPLAY | 石家庄诚志永华显示材料有限公司 | 2021-12-23 | — | — | WO | disclosed |
| US-10400169-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2019-09-03 | — | — | US | disclosed |
| US-10208251-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2019-02-19 | — | — | US | disclosed |
| US-20180086980-A1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME | MERCK PATENT GMBH (DE) | 2018-03-29 | — | — | US | disclosed |
| US-20180030350-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2018-02-01 | — | — | US | disclosed |
| US-20180030350-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2018-02-01 | — | — | US | disclosed |
| US-20170044438-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
| US-20170044438-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
| US-20170044437-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
| US-20170044437-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
| US-20160152587-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2016-06-02 | — | — | US | disclosed |
| US-20160152587-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2016-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044438-A1 | LIQUID-CRYSTALLINE MEDIUM | VIM, COL2A1, COL1A1 | FGFR2 386/4885FGFR1 70/4885ADORA3 2642/4885 |
| US-20180030350-A1 | LIQUID-CRYSTALLINE MEDIUM | VIM, COL2A1, COL1A1 | FGFR2 386/4885FGFR1 70/4885ADORA3 2642/4885 |
| US-10400169-B2 | Liquid-crystalline medium | VIM, COL2A1, COL1A1 | FGFR2 386/4885FGFR1 70/4885ADORA3 2642/4885 |
| US-20170044437-A1 | LIQUID-CRYSTALLINE MEDIUM | VIM, COL2A1, COL1A1 | FGFR2 386/4885FGFR1 70/4885ADORA3 2642/4885 |
| US-10208251-B2 | Liquid-crystalline medium | VIM, COL2A1, COL1A1 | FGFR2 386/4885FGFR1 70/4885ADORA3 2642/4885 |
| US-20160152587-A1 | LIQUID-CRYSTALLINE MEDIUM | VIM, COL2A1, COL1A1 | FGFR2 386/4885FGFR1 70/4885ADORA3 2642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.